Objective
The treatment of HIV patients has been greatly improved by the development overheard. However, despite a strong reduction in the number of virus producing cellsHAART does not fully eradicate the virus, making sustained treatment necessary. In addition, immune function is only partly restored during HAART. Therefore, the focus has recently shifted to supplementing HAART with additional immune therapy. The aim of this project is to develop and test a new protocol for the treatment of HIV patients, based on a combination of anti-retroviral, immune and gene therapies. The main target of this therapy shall be to restore CD4 helper T-cell immune responses. These cells are central immune regulators that largely determine the type and strength of the immune response generated following antigen encounter and thus the efficiency with which a particular infection is controlled by the body.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health sciencesmedical biotechnologygenetic engineeringgene therapy
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health sciencesbasic medicineimmunology
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
You need to log in or register to use this function
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
2288 GJ RIJSWIJK ZH
Netherlands